Leerink Partners Downgrades Veracyte to Market Perform, Lowers Price Target to $35

Benzinga · 4d ago
Leerink Partners analyst Puneet Souda downgrades Veracyte (NASDAQ:VCYT) from Outperform to Market Perform and lowers the price target from $55 to $35.